Healthcare

FDA Approves Medtronic’s New Automated Insulin Pump – WSJ

The U.S. Food and Drug Administration said it has approved an insulin pump by medical device company Medtronic that automatically manages glucose levels within a target range.

Medtronic said it ex­pects the new prod­uct will cost in the range of $6,000 to $9,000 de­pending on the payer and insur­ance plan footing the bill, the same price range Medtronic currently charges for its ex­ist­ing pump-and-mon­i­tor combo called Min­i­Med 630G.

Source: FDA Approves Medtronic’s New Automated Insulin Pump – WSJ

happy_face_scratching_chin_question_md_clrUnaffordable? Ripping us off? Oh my‼️ Where’s Bernie and Old Liz❓We need an independent group to evaluate this pricing, right Hillary⁉️ Na, somebody else is footing the bill … but do you have a high deductible health plan?

Advertisements

1 reply »

  1. And this is exactly my problem with medical / drug cost. Why should the price be dependent on “who is footing the bill”? The price should be based on cost + a reasonable profit, not extra for for poor people without insurance or with medicaid and a discount for the rich who have insurance.

    Like

What's your opinion on this post? Readers would like your point of view.

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s